Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care
Treatment options for CLL continue to evolve. Current treatment selection is based on clinical and patient-specific considerations. Emerging novel therapies to overcome treatment resistance and strategies to optimize supportive care generate opportunities for pharmacists to advance practice and improve patient safety.
Authors
- Clement Chung (ORCID: https://orcid.org/0000-0002-7189-6612)
Institutions
- Houston Methodist (US)
- Methodist Hospital (US)
- Methodist West Hospital (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1093/ajhp/zxaf058
- Citations
- 3
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 4.88